Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | AKT1 | P31749 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 3/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | PAM | P19021 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL792985 | 1.00 | IDO1 (0.63) | IDO1MEN1KMT2AAKT1HTR2A | |
| SCHEMBL7592958 | 1.00 | IDO1 (0.63) | IDO1MEN1KMT2AAKT1HTR2A | |
| Propene SCHEMBL7165211 | 0.92 | IDO1 (0.55) | IDO1MEN1KMT2AAKT1HTR2A | |
| SCHEMBL9615559 | 0.87 | MEN1 (0.57) | IDO1MEN1KMT2AAKT1HTR2A | |
| SCHEMBL29137842 | 0.84 | APP (0.49) | IDO1MEN1KMT2AAKT1RELA | |
| SCHEMBL1657285 | 0.83 | IDO1 (0.59) | IDO1MEN1KMT2AHTR2ATRPA1 | |
| SCHEMBL1657284 | 0.83 | IDO1 (0.59) | IDO1MEN1KMT2AHTR2ATRPA1 | |
| SCHEMBL430935 | 0.81 | IDO1 (0.68) | IDO1HTR2APAMMAOB | |
| SCHEMBL430934 | 0.81 | IDO1 (0.68) | IDO1HTR2APAMMAOB | |
| SCHEMBL452602 | 0.81 | IDO1 (0.68) | IDO1MEN1KMT2AHTR2APAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795378-B2 | Iron control composition, make, and use in carbonate stimulation | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-10-24 | — | — | US | claimed |
| CN-108645925-B | Method for detecting related substances in cinnamyl octane related products through high performance liquid chromatography | 东北制药集团股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| US-20200140747-A1 | Compositions and Methods for Corrosion Inhibition | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-05-07 | — | — | US | claimed |
| CN-107311844-A | The synthesis of m-trifluoromethyl phenylpropanol | 六安佳诺生化科技有限公司 | 2017-11-03 | — | — | CN | claimed |
| CN-104072035-B | A kind of high compressive strength concrete and preparation method thereof | BENGBU EAST CHINA GYPSUM CO., LTD. (CN) | 2015-12-02 | — | — | CN | claimed |
| US-7803846-B2 | Highly durable polymer electrolytic membrane for a fuel cell having a cross-linked structure | JAPAN ATOMIC ENERGY AGENCY (JP) | 2010-09-28 | — | — | US | claimed |
| CN-100506873-C | Radiation cured polyurethanes with capped amino groups | BASF AG (DE) | 2009-07-01 | — | — | CN | claimed |
| US-20080221154-A1 | HIV-INTEGRASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THEIR USE | PFIZER INC | 2008-09-11 | — | — | US | claimed |
| CN-100390261-C | Compositions comprising photo-labile perfume delivery systems | PROCTER & GAMBLE (US) | 2008-05-28 | — | — | CN | claimed |
| US-7368571-B2 | HIV-Integrase inhibitors, pharmaceutical compositions and methods for their use | PFIZER INC (US) | 2008-05-06 | — | — | US | claimed |
| CN-1553948-A | Compositions comprising photo-labile perfume delivery systems | — | 2004-12-08 | — | — | CN | claimed |
| US-20040147547-A1 | HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use | AGOURON PHARMACEUTICALS, INC. | 2004-07-29 | — | — | US | claimed |
| WO-2004039803-A2 | HIV-INTEGRASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THEIR USE | PFIZER INC. (US) | 2004-05-13 | — | — | WO | claimed |
| WO-2002004528-A2 | FRAGMENTABLE CATALYST SUPPORT | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2002-01-17 | — | — | WO | claimed |
| EP-0594608-B1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS | RES CORP TECHNOLOGIES INC (US) | 1997-10-15 | — | — | EP | claimed |
| EP-0594608-A1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. | RES CORP TECHNOLOGIES INC (US) | 1994-05-04 | — | — | EP | claimed |
| EP-0594608-A4 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. | RES CORP TECHNOLOGIES INC (US) | 1993-03-15 | — | — | EP | claimed |
| WO-1991014672-A1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-10-03 | — | — | WO | claimed |
| US-4994539-A | Ethylene-unsaturated aromatic copolymer | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1991-02-19 | — | — | US | claimed |
| US-3943943-A | Cinnamic derivatives as tobacco additives | LIGGETT & MYERS INCORPORATED (US) | 1976-03-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147547-A1 | HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use | IMPDH1, POLA1, POLB | IDO1 45/4885MEN1 4396/4885KMT2A 859/4885 |
| US-20080221154-A1 | HIV-INTEGRASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THEIR USE | TYMP, IMPDH1, POLB | IDO1 103/4885MEN1 4647/4885KMT2A 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.